TrialDigestive diseases and sciences2015

Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab.

Casper Steenholdt et al.PubMed ↗Publisher ↗

No numbers read from the abstract.